Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells

Jeonghyun Ahn, Tianli Xia, Ailem Rabasa Capote, Dillon Betancourt, Glen N Barber

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The ability of dying cells to activate antigen-presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Here, we show that engulfed cells containing cytosolic double-stranded DNA species (viral or synthetic) or cyclic di-nucleotides (CDNs) are able to stimulate APCs via extrinsic STING (stimulator of interferon genes) signaling, to promote antigen cross-presentation. In the absence of STING agonists, dying cells were ineffectual in the stimulation of APCs in trans. Cytosolic STING activators, including CDNs, constitute cellular danger-associated molecular patterns (DAMPs) only generated by viral infection or following DNA damage events that rendered tumor cells highly immunogenic. Our data shed insight into the molecular mechanisms that drive appropriate anti-tumor adaptive immune responses, while averting harmful autoinflammatory disease, and provide a therapeutic strategy for cancer treatment. Ahn et al. show that dying tumor cells that contain STING-dependent adjuvants activate STING signaling in engulfing macrophages to trigger immune responses, cross-presentation of antigens, and generation of cytotoxic T cells, providing a potential cancer therapeutic strategy.

Original languageEnglish (US)
JournalCancer Cell
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Phagocytes
Interferons
Antigen-Presenting Cells
Cross-Priming
Genes
Cyclic Nucleotides
Neoplasms
Antigen Presentation
Adaptive Immunity
Virus Diseases
DNA Damage
Macrophages
T-Lymphocytes
Antigens
DNA
Therapeutics

Keywords

  • anti-tumor T cells
  • antigen-presenting cells (APCs)
  • cyclic di-nucleotides (CDNs)
  • innate immunity
  • interferon
  • STING
  • STING-dependent adjuvants (STAVs)

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells. / Ahn, Jeonghyun; Xia, Tianli; Rabasa Capote, Ailem; Betancourt, Dillon; Barber, Glen N.

In: Cancer Cell, 01.01.2018.

Research output: Contribution to journalArticle

@article{a55c0f3d71e0406190e44eb881a4df50,
title = "Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells",
abstract = "The ability of dying cells to activate antigen-presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Here, we show that engulfed cells containing cytosolic double-stranded DNA species (viral or synthetic) or cyclic di-nucleotides (CDNs) are able to stimulate APCs via extrinsic STING (stimulator of interferon genes) signaling, to promote antigen cross-presentation. In the absence of STING agonists, dying cells were ineffectual in the stimulation of APCs in trans. Cytosolic STING activators, including CDNs, constitute cellular danger-associated molecular patterns (DAMPs) only generated by viral infection or following DNA damage events that rendered tumor cells highly immunogenic. Our data shed insight into the molecular mechanisms that drive appropriate anti-tumor adaptive immune responses, while averting harmful autoinflammatory disease, and provide a therapeutic strategy for cancer treatment. Ahn et al. show that dying tumor cells that contain STING-dependent adjuvants activate STING signaling in engulfing macrophages to trigger immune responses, cross-presentation of antigens, and generation of cytotoxic T cells, providing a potential cancer therapeutic strategy.",
keywords = "anti-tumor T cells, antigen-presenting cells (APCs), cyclic di-nucleotides (CDNs), innate immunity, interferon, STING, STING-dependent adjuvants (STAVs)",
author = "Jeonghyun Ahn and Tianli Xia and {Rabasa Capote}, Ailem and Dillon Betancourt and Barber, {Glen N}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ccell.2018.03.027",
language = "English (US)",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",

}

TY - JOUR

T1 - Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells

AU - Ahn, Jeonghyun

AU - Xia, Tianli

AU - Rabasa Capote, Ailem

AU - Betancourt, Dillon

AU - Barber, Glen N

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The ability of dying cells to activate antigen-presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Here, we show that engulfed cells containing cytosolic double-stranded DNA species (viral or synthetic) or cyclic di-nucleotides (CDNs) are able to stimulate APCs via extrinsic STING (stimulator of interferon genes) signaling, to promote antigen cross-presentation. In the absence of STING agonists, dying cells were ineffectual in the stimulation of APCs in trans. Cytosolic STING activators, including CDNs, constitute cellular danger-associated molecular patterns (DAMPs) only generated by viral infection or following DNA damage events that rendered tumor cells highly immunogenic. Our data shed insight into the molecular mechanisms that drive appropriate anti-tumor adaptive immune responses, while averting harmful autoinflammatory disease, and provide a therapeutic strategy for cancer treatment. Ahn et al. show that dying tumor cells that contain STING-dependent adjuvants activate STING signaling in engulfing macrophages to trigger immune responses, cross-presentation of antigens, and generation of cytotoxic T cells, providing a potential cancer therapeutic strategy.

AB - The ability of dying cells to activate antigen-presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Here, we show that engulfed cells containing cytosolic double-stranded DNA species (viral or synthetic) or cyclic di-nucleotides (CDNs) are able to stimulate APCs via extrinsic STING (stimulator of interferon genes) signaling, to promote antigen cross-presentation. In the absence of STING agonists, dying cells were ineffectual in the stimulation of APCs in trans. Cytosolic STING activators, including CDNs, constitute cellular danger-associated molecular patterns (DAMPs) only generated by viral infection or following DNA damage events that rendered tumor cells highly immunogenic. Our data shed insight into the molecular mechanisms that drive appropriate anti-tumor adaptive immune responses, while averting harmful autoinflammatory disease, and provide a therapeutic strategy for cancer treatment. Ahn et al. show that dying tumor cells that contain STING-dependent adjuvants activate STING signaling in engulfing macrophages to trigger immune responses, cross-presentation of antigens, and generation of cytotoxic T cells, providing a potential cancer therapeutic strategy.

KW - anti-tumor T cells

KW - antigen-presenting cells (APCs)

KW - cyclic di-nucleotides (CDNs)

KW - innate immunity

KW - interferon

KW - STING

KW - STING-dependent adjuvants (STAVs)

UR - http://www.scopus.com/inward/record.url?scp=85045583615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045583615&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2018.03.027

DO - 10.1016/j.ccell.2018.03.027

M3 - Article

C2 - 29706455

AN - SCOPUS:85045583615

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

ER -